Reuven Or

Research interests

Publications

• Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back

  International Journal of Molecular Sciences · 2020 · 10.3390/ijms21124448

• Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back

  International Journal of Molecular Sciences · 2020 · 10.3390/ijms21124448

• Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1917635

• Mesenchymal Stromal Cell-Derived Exosomes Affect mRNA Expression and Function of B-Lymphocytes

  Frontiers in Immunology · 2018 · 10.3389/fimmu.2018.03053

• High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation

  The Journal of Infectious Diseases · 2013 · 10.1093/infdis/jit475

• High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation

  The Journal of Infectious Diseases · 2013 · 10.1093/infdis/jit475

• Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita

  Transplantation and Cellular Therapy · 2013 · 10.1016/j.bbmt.2013.05.021

• Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

  Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2012.48.3685

• Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC).

  PubMed · 2013

• Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita

  Transplantation and Cellular Therapy · 2013 · 10.1016/j.bbmt.2013.05.021

• A randomized study comparing yttrium‐90 ibritumomab tiuxetan (Zevalin) and high‐dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma

  Cancer · 2012 · 10.1002/cncr.27418

• Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

  Blood · 2010 · https://doi.org/10.1182/blood-2010-01-262089

• Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group

  Blood · 2009 · 10.1182/blood-2009-03-207001

• Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation

  Bone Marrow Transplantation · 2007 · 10.1038/sj.bmt.1705550

• The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor‐alloreactive T cells causing GVHD

  Tissue Antigens · 2004 · 10.1111/j.0001-2815.2004.00182.x

• Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase

  Blood · 2002 · 10.1182/blood-2002-02-0535

• Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma

  Bone Marrow Transplantation · 2000 · 10.1038/sj.bmt.1702392

• Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis

  Experimental Hematology · 2000 · 10.1016/s0301-472x(00)00172-7

• Nosocomial Colonization, Septicemia, and Ilickman/Broviac Catheter-Related Infections in Bone Marrow Transplant Recipients: A 5-Year Prospective Study

  Medicine · 1998 · 10.1097/00005792-199803000-00002

• Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

  Blood · 1998 · https://doi.org/10.1182/blood.v91.3.756

• Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

  Blood · 1998 · https://doi.org/10.1182/blood.v91.3.756.756_756_763

• Right atrial thrombi are related to indwelling central venous catheter position: Insights into time course and possible mechanism of formation

  American Heart Journal · 1998 · 10.1016/s0002-8703(98)70322-9

• T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapse

  British Journal of Haematology · 1995 · 10.1111/j.1365-2141.1995.tb08356.x

• Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.

  PubMed · 1995

• Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation

  Hepatology · 1993 · 10.1002/hep.1840180204

• Invasive fungal sinusitis in patients undergoing bone marrow transplantation.

  PubMed · 1993

• Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation

  Hepatology · 1993 · 10.1002/hep.1840180204

• Edta‐dependent pseudothrombocytopenia: A clinical study of 18 patients and a review of the literature

  American Journal of Hematology · 1991 · 10.1002/ajh.2830360307

• ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)

  The Lancet · 1984 · 10.1016/s0140-6736(84)92564-9

Current projects

No projects listed.